1 completed, 1 recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow TQD3524: new trials by email Literature Review of TQD3524 trials Research Report on TQD3524
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study on the Safety and Efficacy of Polymyxin E2 Methanesulfonate for Injection in the Treatment of Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia Caused by Carbapenem-Resistant Gram-Negative Bacteria TQD3524, Meropenem for injection, Colistimethate Sodium for Injection - Hospital-acquired Bacterial Pneumonia/Ventilator-associated Bacterial Pneumonia | Phase 2 | Recruiting | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 48 | 2026-07-21 | 2026-09-04 |
| To Evaluate the Pharmacokinetics and Safety of TQD3524 for Injection in Renal Impairment Subjects TQD3524 - Multi-resistant Gram-negative Bacteria Cause Infection | Phase 1 | Completed | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 48 | 2024-07-24 | 2026-01-09 |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (2)
China (2)